| |
|
|
|
Lipocine Inc.  
|
|
1.04 -0.07 (-0.06%) |
09-21 11:09 |
|
Open: |
1.11 |
Pre close: |
1.11 |
Target:
|
1.55 
|
|
High: |
1.11 |
Low: |
1.04 |
Resistance:
|
1.33
1.49
|
|
Volume: |
575,774 |
Market Cap: |
92M |
Support:
|
1.07
0.89
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.13
|
MACD |
MACD(12,26):
|
-0.07 |
|
MA(20): |
1.24 |
Signal(12,26,9): |
-0.05 |
|
MA(100): |
1.33 |
Stochastic Oscillator |
%K(14,3):
|
8.47 |
|
MA(250): |
1.45 |
%D(3): |
11.63 |
|
Average Volume(K) |
3-Month: |
4835766
|
52-Week |
High:
|
2.42 |
|
10-Days: |
68186 |
Low: |
1.07 |
|
RSI |
RSI(14):
|
29.06 |
Change(%): |
-25.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.283 |
Return on Equity (ttm) |
-77.8 |
Shares Out. (M) |
88.29 |
|
EPS Est. Current Year |
-0.960 |
Return on Assets (ttm) |
-27.0 |
Shares Float (M) |
86.08 |
|
EPS Est. Next Year |
-0.720 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.51 |
|
EPS Est. Next Quarter |
-0.190 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
10.64 |
|
Forward EPS |
-0.500 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
3700 |
|
Book Value (p.s.) |
0.480 |
EBITDA (p.s.) |
-0.173 |
P/E |
-3.78 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.23 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-14.27 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-1.26 |
P/CF |
-6.62 |
|
|
|
|
|
|
